🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

U.S. crosses 300,000 COVID-19 deaths as vaccine rollout begins

Published 2020-12-14, 02:11 p/m
© Reuters. FILE PHOTO: Healthcare personnel work inside a COVID-19 unit in Houston
PFE
-

By Anurag Maan

(Reuters) - The number of coronavirus deaths in the United States crossed 300,000 on Monday, according to Reuters tally, as the hardest hit nation rolled out its first vaccine inoculations on Monday.

The staggering death toll comes as the nation begins a historic inoculation campaign using a vaccine developed by Pfizer Inc (NYSE:PFE) and BioNTech SE. Moderna Inc's vaccine could get approval as soon as this week.

The vaccine comes as COVID-19 cases explode across the nation and hospital intensive care units run out of beds. Daily coronavirus cases and deaths have set records multiple times since Thanksgiving holidays with daily fatalities topping 3,000 for the second time last week on Friday, the same day the vaccine got approval from the Food and Drug Administration.

It took 27 days to go from 250,000 total U.S. COVID-19 deaths to 300,000 - the fastest 50,000-death jump since the pandemic began. Some models project that deaths could reach 500,000 before vaccines become widely available in the spring and summer.

In recent weeks, South Dakota and North Dakota have led the nation in deaths per capita. Overall, New Jersey and New York, early epicenter of the U.S. outbreak, lead the nation in per capita deaths.

The United States recently crossed 16 million confirmed cases - the most in the world.

According to Reuters analysis, the United States is reporting 91 deaths per 100,000 people, seventh worst in the world on a per capita basis and 2.5 times the rate in Canada.

© Reuters. FILE PHOTO: Healthcare personnel work inside a COVID-19 unit in Houston

The nation's hospitals are flooding with COVID-19 patients, threatening to overwhelm healthcare systems and providers. There are over 108,000 hospitalized COVID-19 patients, the highest since the first coronavirus case was detected in the country in January.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.